Brief: Nasdaq Granted China Sxt Pharmaceuticals, Inc. 180-Day Extension To Regain Compliance With Bid Price Requirement
09/09/2020 14:24
Sept 9 (Reuters) - China SXT Pharmaceuticals Inc SXTC.O :
* NASDAQ GRANTED CHINA SXT PHARMACEUTICALS, INC. 180-DAY
EXTENSION
TO REGAIN COMPLIANCE WITH BID PRICE REQUIREMENT
Source text for Eikon: ID:nPn4YH5cka
Further company coverage: SXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China SXT Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Univest Securities, Llc Announces Closing Of $9 Million Registered Direct Offering For Its Client China Sxt Pharmaceuticals Inc. (Nasdaq Sxtc)